Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-223,866
Closed -$101K 7567
2025
Q2
$101K Buy
223,866
+223,260
+36,842% +$97.1K ﹤0.01% 5607
2025
Q1
$0 Buy
606
+326
+116% +$209 ﹤0.01% 7268
2024
Q4
$0 Hold
280
﹤0.01% 7289
2024
Q3
$0 Sell
280
-188
-40% -$144 ﹤0.01% 7509
2024
Q2
$0 Buy
468
+27
+6% +$22 ﹤0.01% 7586
2024
Q1
$1K Sell
441
-4,884
-92% -$5.12K ﹤0.01% 6879
2023
Q4
$3K Buy
5,325
+2,045
+62% +$1.41K ﹤0.01% 6755
2023
Q3
$2K Sell
3,280
-4,950
-60% -$3.77K ﹤0.01% 6823
2023
Q2
$6K Sell
8,230
-2,443
-23% -$2.27K ﹤0.01% 6636
2023
Q1
$8K Sell
10,673
-11,742
-52% -$10.9K ﹤0.01% 6426
2022
Q4
$22K Buy
22,415
+12,909
+136% +$18.2K ﹤0.01% 6268
2022
Q3
$20K Sell
9,506
-1,392
-13% -$4.8K ﹤0.01% 6150
2022
Q2
$38K Sell
10,898
-6,821
-38% -$25.5K ﹤0.01% 5843
2022
Q1
$89K Sell
17,719
-19,902
-53% -$101K ﹤0.01% 5738
2021
Q4
$236K Buy
37,621
+15,918
+73% +$109K ﹤0.01% 5177
2021
Q3
$173K Sell
21,703
-1,677
-7% -$13.8K ﹤0.01% 5304
2021
Q2
$175K Buy
23,380
+8,578
+58% +$59.9K ﹤0.01% 5192
2021
Q1
$90K Buy
14,802
+871
+6% +$6.7K ﹤0.01% 5534
2020
Q4
$79K Buy
13,931
+12,596
+944% +$80.1K ﹤0.01% 5458
2020
Q3
$9K Buy
1,335
+235
+21% +$2.09K ﹤0.01% 5968
2020
Q2
$10K Buy
+1,100
New +$3.16K ﹤0.01% 5840
2019
Q2
Sell
-9
Closed 7217
2019
Q1
$0 Hold
9
﹤0.01% 7134
2018
Q4
$0 Hold
9
﹤0.01% 7150
2018
Q3
$0 Buy
+9
New +$27 ﹤0.01% 6969
2018
Q2
Sell
-3
Closed 6794
2018
Q1
$0 Hold
3
﹤0.01% 6830
2017
Q4
$0 Hold
3
﹤0.01% 6926
2017
Q3
$0 Buy
+3
New +$20 ﹤0.01% 7014
2017
Q2
Sell
-2
Closed 6789
2017
Q1
$0 Buy
+2
New +$20 ﹤0.01% 6844
2013
Q3
Hold
0
6279
2013
Q2
Hold
0
5852

Other funds holding VXRT

Royal Bank of Canada's VXRT Position: Q3 2025 in Review

Royal Bank of Canada sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 223,866 shares — an estimated $101K sold.

Royal Bank of Canada first reported a position in VXRT in Q1 2017 and held it in 28 quarters. The position peaked at $236K in Q4 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Royal Bank of Canada reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 223,866 Vaxart shares in Q3 2025, an estimated $101K.
  • Royal Bank of Canada first reported a position in Vaxart in Q1 2017 and held it in 28 quarters.
  • Royal Bank of Canada's Vaxart position peaked at $236K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.